Critical thinking about adverse drug effects: Lessons from the psychology of risk and medical decision-making for clinical psychopharmacology

被引：12
|
作者：
Nierenberg, Andrew A. [1 ,2 ]
Smoller, Jordan W. [3 ]
Eidelman, Polina [1 ,2 ]
Wu, Yelena P. [1 ,2 ]
Tilley, Claire A. [1 ,2 ]
机构：
[1] Harvard Univ, Depression Clin & Res Programs, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Bipolar Clin & Res Program, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Harvard Univ, Psychiat Genet Program Mood & Anxiety Disorders, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
PSYCHOTHERAPY AND PSYCHOSOMATICS | 2008年 / 77卷 / 04期
关键词：
adverse drug effects; psychology of risk; psychopharmacology;
D O I：
10.1159/000126071
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Systematic biases in decision-making have been well characterized in medical and nonmedical fields but mostly ignored in clinical psychopharmacology. The purpose of this paper is to sensitize clinicians who prescribe psychiatric drugs to the issues of the psychology of risk, especially as they pertain to the risk of side effects. Specifically, the present analysis focuses on heuristic organization and framing effects that create cognitive biases in medical practice. Our purpose is to increase the awareness of how pharmaceutical companies may influence physicians by framing the risk of medication side effects to favor their products. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码：201 / 208
页数：8
相关论文
共 50 条
  • [31] Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products
    Arzu Selen
    Anette Müllertz
    Filippos Kesisoglou
    Rodney J. Y. Ho
    Jack A. Cook
    Paul A. Dickinson
    Talia Flanagan
    The AAPS Journal, 22
  • [32] Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products
    Selen, Arzu
    Mullertz, Anette
    Kesisoglou, Filippos
    Ho, Rodney J. Y.
    Cook, Jack A.
    Dickinson, Paul A.
    Flanagan, Talia
    AAPS JOURNAL, 2020, 22 (05):
  • [33] Considerations of healthcare professionals in medical decision-making about treatment for clinical end-stage cancer patients
    van Leeunven, AF
    Voogt, E
    Visser, A
    van der Rijt, CCD
    van der Heide, A
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 28 (04) : 351 - 355
  • [34] Clinical decision making regarding therapy adjustment using systematic screening of adverse antiepileptic drug effects
    Lukic, S.
    Cojbasic, Z.
    Spasic, M.
    EPILEPSIA, 2006, 47 : 117 - 117
  • [35] Translating Clinical Decision-Making Skills From a Critical Care Pharmacy Elective to the Required Curriculum
    Branan, Trisha N.
    Hawkins, W. Anthony
    Palmer, Russ
    Sikora, Andrea
    Huntt, Kendall
    Phillips, Beth B.
    Clemmons, Amber B.
    Bland, Christopher M.
    Smith, Susan E.
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2024, 88 (01)
  • [36] Ethics update: lessons learned from Terri Schiavo: the importance of healthcare proxies in clinical decision-making
    Cohen, Neal H.
    Kummer, Heidi B.
    CURRENT OPINION IN ANESTHESIOLOGY, 2006, 19 (02) : 122 - 126
  • [37] From Value Assessment to Value Cocreation: Informing Clinical Decision-Making with Medical Claims Data
    Thompson, Steven
    Varvel, Stephen
    Sasinowski, Maciek
    Burke, James P.
    BIG DATA, 2016, 4 (03) : 141 - 147
  • [38] Exploring the impact of collaborative learning on the development of critical thinking and clinical decision-making skills in nursing students: A quantitative descriptive design
    Eskiyurt, Reyhan
    Ozkan, Birgul
    HELIYON, 2024, 10 (17)
  • [39] Objective numeracy exacerbates framing effects from decision-making under political risk
    Fitz, Erin B.
    Stecula, Dominik A.
    Hitt, Matthew P.
    Saunders, Kyle L.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Correction to: Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products
    Arzu Selen
    Anette Müllertz
    Filippos Kesisoglou
    Rodney J. Y. Ho
    Jack A. Cook
    Paul A. Dickinson
    Talia Flanagan
    The AAPS Journal, 23
12345